KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Clover Health Investments (CLOV) FCF Margin (2020 - 2025)

Clover Health Investments' FCF Margin history spans 6 years, with the latest figure at 14.1% for Q4 2025.

  • For Q4 2025, FCF Margin rose 1252.0% year-over-year to 14.1%; the TTM value through Dec 2025 reached 3.59%, down 600.0%, while the annual FY2025 figure was 3.58%, 601.0% down from the prior year.
  • FCF Margin reached 14.1% in Q4 2025 per CLOV's latest filing, down from 2.3% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 37.85% in Q3 2022 to a low of 116.14% in Q4 2022.
  • Average FCF Margin over 5 years is 12.75%, with a median of 4.13% recorded in 2022.
  • Peak YoY movement for FCF Margin: plummeted -7613bps in 2022, then soared 5845bps in 2024.
  • A 5-year view of FCF Margin shows it stood at 40.0% in 2021, then crashed by -190bps to 116.14% in 2022, then increased by 27bps to 85.07% in 2023, then surged by 69bps to 26.62% in 2024, then surged by 47bps to 14.1% in 2025.
  • Per Business Quant, the three most recent readings for CLOV's FCF Margin are 14.1% (Q4 2025), 2.3% (Q3 2025), and 1.01% (Q2 2025).